Plus Therapeutics - 24 Year Stock Price History | PSTV

Historical daily share price chart and data for Plus Therapeutics since 2001 adjusted for splits and dividends. The latest closing stock price for Plus Therapeutics as of May 02, 2025 is 0.65.
  • The all-time high Plus Therapeutics stock closing price was 1000000.00 on November 11, 2005.
  • The Plus Therapeutics 52-week high stock price is 2.67, which is 310.8% above the current share price.
  • The Plus Therapeutics 52-week low stock price is 0.24, which is 63.1% below the current share price.
  • The average Plus Therapeutics stock price for the last 52 weeks is 1.39.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Plus Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.0228 1.1800 1.5700 0.3000 0.6479 -43.66%
2024 1.6851 1.8500 2.6000 0.9900 1.1500 -34.29%
2023 3.2082 4.6500 7.2000 1.0100 1.7500 -63.54%
2022 10.1056 16.3500 19.8000 4.5000 4.8000 -69.52%
2021 32.4524 31.6500 56.2500 15.4500 15.7500 -48.02%
2020 32.6496 39.7500 47.5500 15.7500 30.3000 -15.83%
2019 149.1429 240.0000 292.5000 29.8500 36.0000 -83.45%
2018 1318.1175 2175.0000 3750.0000 202.5000 217.5000 -90.33%
2017 6779.8805 12000.0000 14925.0000 1725.0000 2250.0000 -80.13%
2016 18043.7500 21375.0000 39375.0000 10200.0000 11325.0000 -47.02%
2015 65593.7500 58500.0000 154125.0000 21375.0000 21375.0000 -61.22%
2014 206080.3571 283500.0000 373500.0000 42750.0000 55125.0000 -80.93%
2013 284066.9643 319500.0000 376875.0000 231750.0000 289125.0000 -8.21%
2012 340681.5000 256500.0000 534375.0000 228375.0000 315000.0000 27.27%
2011 526084.8214 606375.0000 928125.0000 221625.0000 247500.0000 -57.61%
2010 588619.0476 699750.0000 1000000.0000 383625.0000 583875.0000 -14.92%
2009 390647.3214 405000.0000 739125.0000 175500.0000 686250.0000 68.98%
2008 604405.1383 687375.0000 963000.0000 212625.0000 406125.0000 -40.33%
2007 640801.7928 720000.0000 745875.0000 523125.0000 680625.0000 -7.49%
2006 724109.5618 931500.0000 1000000.0000 451125.0000 735750.0000 -21.20%
2005 509188.9881 267750.0000 1000000.0000 258750.0000 933750.0000 201.82%
2004 380107.1429 343125.0000 506250.0000 281250.0000 309375.0000 -9.84%
2003 400209.8214 450000.0000 502875.0000 326250.0000 343125.0000 -23.75%
2002 418138.3929 378000.0000 562500.0000 309375.0000 450000.0000 25.00%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.011B $0.006B
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $98.106B 36.80
Zoetis (ZTS) US $70.247B 26.59
Daiichi Sankyo, - (DSNKY) JP $49.445B 25.16
Takeda Pharmaceutical (TAK) JP $48.747B 10.79
Summit Therapeutics (SMMT) US $20.720B 0.00
Sandoz Group AG (SDZNY) CH $19.545B 0.00
Merck (MKKGY) DE $18.346B 15.18
Shionogi (SGIOY) JP $14.436B 0.00
United Therapeutics (UTHR) US $13.288B 11.76
Neurocrine Biosciences (NBIX) US $10.852B 33.34
IPSEN (IPSEY) FR $9.920B 0.00
Orion OYJ (ORINY) FI $8.948B 24.20
Corcept Therapeutics (CORT) US $7.717B 58.69
Madrigal Pharmaceuticals (MDGL) US $7.005B 0.00
Stevanato Group S.p.A (STVN) IT $6.475B 41.12
Ono Pharmaceutical (OPHLF) JP $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) GB $5.813B 0.00
Ionis Pharmaceuticals (IONS) US $5.217B 0.00
Grifols, S.A (GRFS) ES $5.054B 0.00
Soleno Therapeutics (SLNO) US $3.755B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.161B 0.00
Catalyst Pharmaceuticals (CPRX) US $3.029B 12.30
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.470B 13.51
Hypermarcas (HYPMY) BR $2.350B 15.46
Recursion Pharmaceuticals (RXRX) US $2.291B 0.00
NewAmsterdam Pharma (NAMS) NL $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.868B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.813B 0.00
Indivior (INDV) US $1.652B 7.01
Guardian Pharmacy Services (GRDN) US $1.632B 0.00
Evotec AG (EVO) DE $1.523B 0.00
ARS Pharmaceuticals (SPRY) US $1.420B 180.75
Ocular Therapeutix (OCUL) US $1.402B 0.00
Dyne Therapeutics (DYN) US $1.348B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.122B 45.61
Enliven Therapeutics (ELVN) US $1.006B 0.00
Ardelyx (ARDX) US $0.988B 0.00
Harrow (HROW) US $0.948B 0.00
Collegium Pharmaceutical (COLL) US $0.888B 4.72
Avadel Pharmaceuticals (AVDL) IE $0.840B 0.00
Xencor (XNCR) US $0.801B 0.00
AleAnna (ANNA) US $0.758B 0.00
Xeris Biopharma Holdings (XERS) US $0.737B 0.00
Cronos Group (CRON) CA $0.709B 0.00
KalVista Pharmaceuticals (KALV) US $0.674B 0.00
Organogenesis (ORGO) US $0.670B 0.00
Akebia Therapeutics (AKBA) US $0.641B 0.00
Bioventus (BVS) US $0.601B 15.62
Savara (SVRA) US $0.587B 0.00
USANA Health Sciences (USNA) US $0.555B 11.92
Relay Therapeutics (RLAY) US $0.554B 0.00
Regulus Therapeutics (RGLS) US $0.520B 0.00
Theravance Biopharma (TBPH) KY $0.519B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.474B 0.00
Verve Therapeutics (VERV) US $0.463B 0.00
Elite Pharmaceuticals (ELTP) US $0.453B 0.00
Altimmune (ALT) US $0.444B 0.00
Zevra Therapeutics (ZVRA) US $0.437B 0.00
Tourmaline Bio (TRML) US $0.419B 0.00
CytoDyn (CYDY) US $0.405B 0.00
Siga Technologies (SIGA) US $0.402B 6.87
Oruka Therapeutics (ORKA) US $0.401B 0.00
Heron Therapeutics (HRTX) US $0.352B 0.00
Rigel Pharmaceuticals (RIGL) US $0.346B 20.60
Aquestive Therapeutics (AQST) US $0.298B 0.00
Avita Medical (RCEL) US $0.244B 0.00
Wellgistics Health (WGRX) US $0.232B 0.00
ProKidney (PROK) US $0.231B 0.00
Nature's Sunshine Products (NATR) US $0.231B 27.15
Esperion Therapeutics (ESPR) US $0.216B 27.25
OmniAb (OABI) US $0.214B 0.00
Korro Bio (KRRO) US $0.197B 0.00
Larimar Therapeutics (LRMR) US $0.190B 0.00
MediWound (MDWD) IL $0.186B 0.00
4D Molecular Therapeutics (FDMT) US $0.174B 0.00
Aldeyra Therapeutics (ALDX) US $0.168B 0.00
Inhibikase Therapeutics (IKT) US $0.167B 0.00
Journey Medical (DERM) US $0.162B 0.00
Nanobiotix S.A (NBTX) FR $0.157B 0.00
Profound Medical (PROF) CA $0.157B 0.00
Aclaris Therapeutics (ACRS) US $0.156B 0.00
Lexeo Therapeutics (LXEO) US $0.154B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.151B 46.62
Procaps Group, S.A (PROCF) LU $0.141B 0.00
Nektar Therapeutics (NKTR) US $0.140B 0.00
Protara Therapeutics (TARA) US $0.138B 0.00
Lyell Immunopharma (LYEL) US $0.136B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.129B 0.00
Enanta Pharmaceuticals (ENTA) US $0.127B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
VAXART, INC (VXRT) US $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.095B 0.00
OptiNose (OPTN) US $0.095B 0.00
Cardiol Therapeutics (CRDL) CA $0.094B 0.00
Achieve Life Sciences (ACHV) CA $0.089B 0.00
Galectin Therapeutics (GALT) US $0.088B 0.00
Arch Biopartners (ACHFF) CA $0.083B 0.00
Dominari Holdings (DOMH) US $0.083B 0.00
Champions Oncology (CSBR) US $0.080B 13.11
Unicycive Therapeutics (UNCY) US $0.078B 0.00
Pyxis Oncology (PYXS) US $0.078B 0.00
Context Therapeutics (CNTX) US $0.078B 0.00
Cassava Sciences (SAVA) US $0.078B 0.00
Fractyl Health (GUTS) US $0.077B 0.00
Telomir Pharmaceuticals (TELO) US $0.077B 0.00
ESSA Pharma (EPIX) CA $0.077B 0.00
Nutriband (NTRB) US $0.071B 0.00
Inotiv (NOTV) US $0.068B 0.00
Karyopharm Therapeutics (KPTI) US $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.063B 0.00
Assertio Holdings (ASRT) US $0.062B 0.00
Vivani Medical (VANI) US $0.062B 0.00
Gain Therapeutics (GANX) US $0.061B 0.00
Metagenomi (MGX) US $0.060B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Avalo Therapeutics (AVTX) US $0.055B 0.00
PMV Pharmaceuticals (PMVP) US $0.052B 0.00
ElectroCore (ECOR) US $0.049B 0.00
Century Therapeutics (IPSC) US $0.047B 0.00
Mural Oncology (MURA) IE $0.046B 0.00
Acrivon Therapeutics (ACRV) US $0.044B 0.00
Verrica Pharmaceuticals (VRCA) US $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.041B 0.00
SCYNEXIS (SCYX) US $0.040B 0.00
Iterum Therapeutics (ITRM) IE $0.039B 0.00
Prelude Therapeutics (PRLD) US $0.039B 0.00
Rafael Holdings (RFL) US $0.038B 0.00
NRx Pharmaceuticals (NRXP) US $0.035B 0.00
FibroGen (FGEN) US $0.034B 0.00
Surrozen (SRZN) US $0.033B 0.00
PolyPid (PYPD) IL $0.028B 0.00
Tempest Therapeutics (TPST) US $0.026B 0.00
CASI Pharmaceuticals (CASI) CN $0.024B 0.00
BioVie (BIVI) US $0.022B 0.00
Enlivex Therapeutics (ENLV) IL $0.022B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
VYNE Therapeutics (VYNE) US $0.021B 0.00
Mannatech (MTEX) US $0.020B 7.75
DURECT (DRRX) US $0.019B 0.00
Natural Alternatives (NAII) US $0.018B 0.00
Lipocine (LPCN) US $0.018B 0.00
GlycoMimetics (GLYC) US $0.017B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
Vivos Therapeutics (VVOS) US $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.014B 0.00
ProPhase Labs (PRPH) US $0.014B 0.00
MEI Pharma (MEIP) US $0.014B 0.00
Cosmos Health (COSM) US $0.012B 0.00
Relmada Therapeutics (RLMD) US $0.012B 0.00
TransCode Therapeutics (RNAZ) US $0.012B 0.00
Scienture Holdings (SCNX) US $0.012B 0.00
Minerva Neurosciences (NERV) US $0.012B 8.95
BioLineRx (BLRX) IL $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.011B 0.00
Carisma Therapeutics (CARM) US $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.010B 3.19
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Biomerica (BMRA) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Jaguar Animal Health (JAGX) US $0.009B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Ainos (AIMD) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Citius Pharmaceuticals (CTXR) US $0.008B 0.00
Indaptus Therapeutics (INDP) US $0.007B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Conduit Pharmaceuticals (CDT) US $0.006B 0.00
NLS Pharmaceutics (NLSP) CH $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
Klotho Neurosciences (KLTO) US $0.005B 0.00
CERo Therapeutics Holdings (CERO) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
Alaunos Therapeutics (TCRT) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.003B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Incannex Healthcare (IXHL) AU $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.002B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Heatwurx (PCSA) US $0.001B 0.00
Petros Pharmaceuticals (PTPI) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Aditxt (ADTX) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00